BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 35046344)

  • 1. [Conversion Surgery following Second-Line Chemotherapy for Unresectable Gastric Cancer].
    Ishiguro T; Mochiki E; Ito T; Ishikawa H; Yamamoto E; Sato T; Chikatani K; Yamamoto A; Chika N; Toyomasu Y; Hatano S; Kumagai Y; Ishibashi K; Maki A; Ishida H
    Gan To Kagaku Ryoho; 2021 Dec; 48(13):1828-1830. PubMed ID: 35046344
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prognostic Significance of Conversion Surgery Following First- or Second-line Chemotherapy for Unresectable Gastric Cancer.
    Fukuchi M; Mochiki E; Ishiguro T; Kumagai Y; Ishibashi K; Ishida H
    Anticancer Res; 2018 Nov; 38(11):6473-6478. PubMed ID: 30396974
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Survival benefit of conversion surgery after intensive chemotherapy for unresectable metastatic gastric cancer: a propensity score-matching analysis.
    Ohnuma H; Sato Y; Onoyama N; Hamaguchi K; Hayasaka N; Sato M; Murase K; Takada K; Miyanishi K; Murakami T; Ito T; Nobuoka T; Takemasa I; Kato J
    J Cancer Res Clin Oncol; 2021 Aug; 147(8):2385-2396. PubMed ID: 33534051
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prognostic Role of Conversion Surgery for Unresectable Gastric Cancer.
    Fukuchi M; Ishiguro T; Ogata K; Suzuki O; Kumagai Y; Ishibashi K; Ishida H; Kuwano H; Mochiki E
    Ann Surg Oncol; 2015 Oct; 22(11):3618-24. PubMed ID: 25663597
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy of Conversion Surgery Following S-1 plus Cisplatin or Oxaliplatin Chemotherapy for Unresectable Gastric Cancer.
    Fukuchi M; Mochiki E; Ishiguro T; Ogura T; Sobajima J; Kumagai Y; Ishibashi K; Ishida H
    Anticancer Res; 2017 Mar; 37(3):1343-1347. PubMed ID: 28314301
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Conversion therapy for inoperable advanced gastric cancer patients by docetaxel, cisplatin, and S-1 (DCS) chemotherapy: a multi-institutional retrospective study.
    Sato Y; Ohnuma H; Nobuoka T; Hirakawa M; Sagawa T; Fujikawa K; Takahashi Y; Shinya M; Katsuki S; Takahashi M; Maeda M; Okagawa Y; Naoki U; Kikuch S; Okamoto K; Miyamoto H; Shimada M; Takemasa I; Kato J; Takayama T
    Gastric Cancer; 2017 May; 20(3):517-526. PubMed ID: 27553665
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Examination of outcomes after conversion surgery for Stage IVGastric cancer in our hospital].
    Hagino S; Kurata T; Makita N; Tsuneda A; Iwata K; Kiriyama M
    Gan To Kagaku Ryoho; 2014 Nov; 41(12):2293-5. PubMed ID: 25731500
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Clinical significance and efficacy of conversion surgery for patients with stage IV gastric cancer].
    Zhu Z
    Zhonghua Wei Chang Wai Ke Za Zhi; 2018 Oct; 21(10):1087-1092. PubMed ID: 30370504
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatment strategy for successful conversion surgery in clinical stage IVB gastric cancer.
    Hojo Y; Ishida Y; Tomita T; Kurahashi Y; Nakamura T; Kitayama Y; Nakao E; Kohno S; Murakami M; Takeuchi J; Takagawa T; Hirota S; Shinohara H
    Eur J Surg Oncol; 2024 Feb; 50(2):107314. PubMed ID: 38101115
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [The Implications of Conversion Surgery for Stage Ⅳ Gastric Cancer].
    Uraoka M; Higashida M; Ueno M; Mineta S; Okamoto Y; Kubota H; Watanabe Y; Okada T; Tsuruta A; Fujiwara Y; Ueno T
    Gan To Kagaku Ryoho; 2018 Dec; 45(13):1797-1799. PubMed ID: 30692357
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The long-term survival of stage IV gastric cancer patients with conversion therapy.
    Yamaguchi K; Yoshida K; Tanahashi T; Takahashi T; Matsuhashi N; Tanaka Y; Tanabe K; Ohdan H
    Gastric Cancer; 2018 Mar; 21(2):315-323. PubMed ID: 28616743
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Surgery after preoperative chemotherapy for patients with unresectable advanced gastric cancer.
    Yamamoto M; Sakaguchi Y; Matsuyama A; Yoshinaga K; Tsutsui S; Ishida T
    Oncology; 2013; 85(4):241-7. PubMed ID: 24107642
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy of conversion gastrectomy following docetaxel, cisplatin, and S-1 therapy in potentially resectable stage IV gastric cancer.
    Kinoshita J; Fushida S; Tsukada T; Oyama K; Okamoto K; Makino I; Nakamura K; Miyashita T; Tajima H; Takamura H; Ninomiya I; Ohta T
    Eur J Surg Oncol; 2015 Oct; 41(10):1354-60. PubMed ID: 26028256
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Progress in conversion therapy for originally unresectable gastric cancer].
    Chen X; Lin Z; Chen Y; Luo J; Zhu Y; Liu H; Li G; Yu J
    Zhonghua Wei Chang Wai Ke Za Zhi; 2018 Oct; 21(10):1191-1195. PubMed ID: 30370519
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Evaluation of conversion gastrectomy for treatment of Stage IV advanced gastric cancer].
    Funaki H; Fujita J; Morioka E; Kaida D; Ohnishi T; Ohno Y; Tomita Y; Noguchi M; Fujita H; Kinami S; Nakano Y; Ueda N; Kosaka T
    Gan To Kagaku Ryoho; 2013 Nov; 40(12):1615-7. PubMed ID: 24393866
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [The Clinical Outcome of Conversion Surgery for Unresectable Gastric Cancers in Our Institution].
    Gunji H; Sakuramoto S; Aratani K; Chuman M; Wakata M; Miyawaki Y; Sato H; Okamoto K; Yamaguchi S; Koyama I
    Gan To Kagaku Ryoho; 2017 Nov; 44(12):1458-1460. PubMed ID: 29394667
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Conversion surgery for stage IV gastric cancer with a complete pathological response to nivolumab: a case report.
    Matsumoto R; Arigami T; Matsushita D; Okubo K; Tanaka T; Yanagita S; Sasaki K; Noda M; Kita Y; Mori S; Kurahara H; Ohtsuka T
    World J Surg Oncol; 2020 Jul; 18(1):179. PubMed ID: 32693806
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Retrospective analysis of generalized chemotherapy for unresectable advanced gastric cancer].
    Miura T; Nakamura J; Yamada S; Nakazawa Y; Ozeki Y; Miura T; Yanagi M; Takahashi T
    Gan To Kagaku Ryoho; 2010 Jan; 37(1):77-81. PubMed ID: 20087036
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Curative Gastrectomy with Perioperative Chemotherapy Improves the Survival for Unresectable Gastric Cancer.
    Otowa Y; Suzuki S; Kanaji S; Harada H; Tanaka T; Yamamoto M; Matsuda Y; Oshikiri T; Nakamura T; Kakeji Y
    Anticancer Res; 2018 Apr; 38(4):2363-2368. PubMed ID: 29599362
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Conversion surgery after combination chemotherapy of docetaxel, cisplatin and S-1 (DCS) for far-advanced gastric cancer.
    Mieno H; Yamashita K; Hosoda K; Moriya H; Higuchi K; Azuma M; Komori S; Yoshida T; Tanabe S; Koizumi W; Katada N; Watanabe M
    Surg Today; 2017 Oct; 47(10):1249-1258. PubMed ID: 28365892
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.